AKT3 and ovarian cancer: DCN (Decorin), AKT3 (AKT Serine/Threonine Kinase 3), and TIMP2 (tissue inhibitor of metalloproteinases 2) are the other novel candidate target genes for miR-182 involved in the regulation of ovarian cancer biological processes [173].